A carregar...
TP53 Mutations Promote Immunogenic Activity in Breast Cancer
BACKGROUND: Although immunotherapy has recently achieved clinical successes in a variety of cancers, thus far there is no immunotherapeutic strategy for breast cancer (BC). Thus, it is important to discover biomarkers for identifying BC patients responsive to immunotherapy. TP53 mutations were often...
Na minha lista:
| Publicado no: | J Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6582869/ https://ncbi.nlm.nih.gov/pubmed/31275382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/5952836 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|